| HOME >> MEDICINE >> TECHNOLOGY |
84-9,277124 Royalty revenue 20267793Total1,04399113,2333,981Operating costs and expenses Cost of product sales8471,0803,3503,687 Research and development1,7281,6787,4955,437 Selling, general and administrative
1,2871,2925,9145,734Total operating costs and expenses
3,8624,05016,75914,858Loss from operations(2,819)(3,059)(3,526)(10,877)Interest and other income(7)(1)2634Interest expense-(22)(11)(112)Net loss before income tax benefit
(2,826)(3,082)(3,511)(10,955)Income tax benefit-31-31Net loss$
(2,826)$
(3,051)$
(3,511)$
(10,924)Basic and diluted net loss per share
$
(0.11)$
(0.13)$
(0.14)$
(0.50)Shares used in computing basic and diluted net loss per share
26,54524,00025,62021,927Balance Sheets(amounts in thousands)June 30,June 30,20112010Assets(unaudited)Cash and cash equivalents
$
8,332$
,561Short-term investments993-Accounts receivable 327376Inventories8401,131Other assets9781,723Total assets$
,470$
9,791Liabilities and stockholders' equityAccounts payable and other liabilities
$
,488$
,511Short term debt-1,400Deferred revenue1,114403Total stockholders' equity8,8686,477Total liabilities and stockholders' equity
$
,470$
9,791
'/>"/>
| SOURCE Cardica, Inc. Copyright©2010 PR Newswire. All rights reserved |